Abstract

Adjusted-dose warfarin and aspirin reduce stroke in patients with atrial fibrillation, and warfarin is substantially more efficacious than aspirin. The benefit of antithrombotic therapy was not offset by the occurrence of major hemorrhage among participants in randomized trials. Judicious use of antithrombotic therapy, tailored according to the inherent risk for stroke, importantly reduces stroke in patients with atrial fibrillation.

Keywords

MedicineAntithromboticAspirinWarfarinAtrial fibrillationStroke (engine)Randomized controlled trialXimelagatranInternal medicineFibrinolytic agentAbsolute risk reductionCardiologyConfidence intervalDabigatran

Affiliated Institutions

Related Publications

Publication Info

Year
1999
Type
review
Volume
131
Issue
7
Pages
492-501
Citations
1627
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

1627
OpenAlex

Cite This

Robert G. Hart, Oscar Benavente, Ruth McBride et al. (1999). Antithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation. Annals of Internal Medicine , 131 (7) , 492-501. https://doi.org/10.7326/0003-4819-131-7-199910050-00003

Identifiers

DOI
10.7326/0003-4819-131-7-199910050-00003